Loading company
Mobia Medical, Inc.
MOBI · Nasdaq · ·
Next earnings: November 10, 2026
$9.04+2.4%Sep 29 close
- 1M
- -20.3%
- 6M
- +326.2%
- 1Y
- +326.2%
- 5Y
- +326.2%
MOBI · Nasdaq · ·
Next earnings: November 10, 2026
$9.04+2.4%Sep 29 close
Mobia Medical, Inc. is scheduled to report next on November 10, 2026. The date comes from Nasdaq’s earnings calendar, and companies sometimes move it.
From the company’s own 8-K filing.
Mobia Medical, Inc. has no earnings call transcript available.
“We delivered a strong second quarter, with revenue more than doubling year-over-year, reflecting consistent growth and increased momentum in our commercial organization,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
Releases land after the close or before the open, so the move is the session that follows.
Mobia Medical, Inc. is a medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The Company’s Vivistim® Paired VNS System is the first and only clinically validated, FDA-approved implantable solution designed to improve upper limb function in chronic ischemic stroke survivors with moderate to severe upper extremity impairments. Therapy with the Vivistim® Paired VNS System combines targeted vagus nerve stimulation with functional movement to promote neuroplasticity and drive meaningful improvements in motor function. Mobia Medical is mobilizing patients, providers, and care partners to establish a better way forward in stroke care.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Mobia Medical, Inc.’s Item 2.02 8-K filed August 11, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.